BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 33114183)

  • 1. Transforming Growth Factor-β: A Multifunctional Regulator of Cancer Immunity.
    Xue VW; Chung JY; Córdoba CAG; Cheung AH; Kang W; Lam EW; Leung KT; To KF; Lan HY; Tang PM
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33114183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β signaling networks in the tumor microenvironment.
    Chan MK; Chung JY; Tang PC; Chan AS; Ho JY; Lin TP; Chen J; Leung KT; To KF; Lan HY; Tang PM
    Cancer Lett; 2022 Dec; 550():215925. PubMed ID: 36183857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy.
    Chan MK; Chan EL; Ji ZZ; Chan AS; Li C; Leung KT; To KF; Tang PM
    Explor Target Antitumor Ther; 2023; 4(2):316-343. PubMed ID: 37205317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapy.
    Ahmadi A; Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Aug; 234(8):12173-12187. PubMed ID: 30537043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dynamic roles of TGF-β in cancer.
    Meulmeester E; Ten Dijke P
    J Pathol; 2011 Jan; 223(2):205-18. PubMed ID: 20957627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGF-β and the Tissue Microenvironment: Relevance in Fibrosis and Cancer.
    Caja L; Dituri F; Mancarella S; Caballero-Diaz D; Moustakas A; Giannelli G; Fabregat I
    Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29701666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF beta signalling and its role in tumour pathogenesis.
    Kaminska B; Wesolowska A; Danilkiewicz M
    Acta Biochim Pol; 2005; 52(2):329-37. PubMed ID: 15990918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming Growth Factor-β Signaling Pathway in Colorectal Cancer and Its Tumor Microenvironment.
    Itatani Y; Kawada K; Sakai Y
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31756952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transforming growth factor-beta (TGF-beta) and brain tumours.
    Luwor RB; Kaye AH; Zhu HJ
    J Clin Neurosci; 2008 Aug; 15(8):845-55. PubMed ID: 18550374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between TGF-β signaling and miRNAs in breast cancer metastasis.
    Chen W; Zhou S; Mao L; Zhang H; Sun D; Zhang J; Li J; Tang JH
    Tumour Biol; 2016 Aug; 37(8):10011-9. PubMed ID: 27153853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TGF-beta signalling and immunity in prostate tumourigenesis.
    Diener KR; Need EF; Buchanan G; Hayball JD
    Expert Opin Ther Targets; 2010 Feb; 14(2):179-92. PubMed ID: 20055717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Glypican-1 in the Tumour Microenvironment.
    Lund ME; Campbell DH; Walsh BJ
    Adv Exp Med Biol; 2020; 1245():163-176. PubMed ID: 32266658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activins in reproductive biology and beyond.
    Wijayarathna R; de Kretser DM
    Hum Reprod Update; 2016 Apr; 22(3):342-57. PubMed ID: 26884470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the transforming growth factor-beta signalling pathway in metastatic cancer.
    Korpal M; Kang Y
    Eur J Cancer; 2010 May; 46(7):1232-40. PubMed ID: 20307969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGF-beta: a master switch in tumor immunity.
    Gigante M; Gesualdo L; Ranieri E
    Curr Pharm Des; 2012; 18(27):4126-34. PubMed ID: 22630082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.
    MacKay SL; Yaswen LR; Tarnuzzer RW; Moldawer LL; Bland KI; Copeland EM; Schultz GS
    Ann Surg; 1995 Jun; 221(6):767-76; discussion 776-7. PubMed ID: 7794080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment.
    Brown NF; Marshall JF
    Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31438626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of TGF-β in melanoma.
    Busse A; Keilholz U
    Curr Pharm Biotechnol; 2011 Dec; 12(12):2165-75. PubMed ID: 21619542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese medicine Bu-Fei decoction attenuates epithelial-mesenchymal transition of non-small cell lung cancer via inhibition of transforming growth factor β1 signaling pathway in vitro and in vivo.
    He XR; Han SY; Li XH; Zheng WX; Pang LN; Jiang ST; Li PP
    J Ethnopharmacol; 2017 May; 204():45-57. PubMed ID: 28412214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In situ analysis of transforming growth factors-beta (TGF-beta 1, TGF-beta 2, TGF-beta 3) and TGF-beta type II receptor expression in basal cell carcinomas.
    Schmid P; Itin P; Rufli T
    Br J Dermatol; 1996 Jun; 134(6):1044-51. PubMed ID: 8763422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.